• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications.
595 Background: The NEAT study reported that Epirubicin x 4 cycles followed by cCMF x 4 cycles (ECMF) is well tolerated and provides a 30% relative reduction in risk of relapse or death compared to(More)